Recruiting now—Ages 18 Years to 75 Years
Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site
Sponsor: Fujian Medical University · NCT03716089 on ClinicalTrials.gov ↗
Conditions studied
GIST of StomachGastric CancerSurgeryComplication
What it tests
- Laparoscopic resectionprocedure
Where it's running1 site
1 international site
- Recruiting now
Fujian Medical University Union Hospital
Fuzhou, Fujian, China 350001
- Changming Huang, Professor(contact)+8613805069676[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: 1. Age between 18 and 75 years old 2. Primary gastric lesion confirmed pathologically GIST by endoscopic biopsy. Preoperative endoscopy, ultrasound endoscopy or computer tomography, Magnetic resonance suspected GIST, and then postoperative pathology confirmed as the original GIST 3. Written informed consent 4. Expected R0 resection by laparoscopy 5. Performance status of 0 or 1 on the ECOG (Eastern Cooperative Oncology Group) scale 6. ASA (American Society of Anesthesiology) class I to III 7. Maximum tumor diameter ≤10cm Exclusion Criteria: 1. Pregnant and lactating women 2. Suffering from a severe mental disorder 3. History of previous upper abdominal surgery (except for laparoscopic cholecystectomy) 4. History of previous gastric surgery (including ESD/EMR for gastric cancer) 5. Rejection of laparoscopic resection 6. History of other malignant disease within the past five years 7. History of unstable angina or myocardial infarction within the past six months 8. History of a cerebrovascular accident within the past six months 9. History of continuous systematic administration of corticosteroids within one month 10. Requirement of simultaneous surgery for another disease 11. Emergency surgery due to complications (bleeding, obstruction or perforation) caused by gastric cancer 12. FEV1\<50% of the predicted values 13. Maximum tumor diameter \>10cm
Updated 2025-04-08 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.